802. Chemical Biology and Experimental Therapeutics: Poster I

Development and characterization of a potent and selective BLIMP1 protac as a novel first in class therapy for multiple myeloma

Translational investigation of tolinapant ASTX660 in Acute Myeloid Leukemia using integrated clinical bioinformatic and pharmacological approaches

Development of a NO probe cell imaging method based on CD58 expression in diffuse large B cell lymphoma and as a tool to predict CAR T efficacy

Targeting B cell lymphoma surface protein with a novel peptide Therapeutic potential and clinical implications

Novel small molecule inhibitors of mitochondrial permeability transition pore mPTP block platelet procoagulant activity

Efficacy of the JAK2 FLT3 inhibitor pacritinib in NPM1 mutated Acute Myeloid Leukemia

Global proteomic profiling of tgrx 3247 a heterobifunctional degrader for the treatment of BCR ABL1 driven chronic myeloid leukemia

FerroEVs drive serial propagation of pharmacologically induced ferroptosis in acute leukemia cells